Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression
Published in
Hematology, Transfusion and Cell Therapy, July 2024
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 July 2025.
All research outputs
#12,406,857
of 34,492,055 outputs
Outputs from Hematology, Transfusion and Cell Therapy
#91
of 384 outputs
Outputs of similar age
#114,925
of 341,752 outputs
Outputs of similar age from Hematology, Transfusion and Cell Therapy
#2
of 2 outputs
Altmetric has tracked 34,492,055 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 384 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.
